Information notices and patient consent forms made available for genetic testing in a health care setting (rare diseases and cancers).

In June 2019, information notices and consent forms – in their various forms: rare diseases, cancer; adults, minors, protected persons– were made available to the genomic platforms of the plan to be used during interviews with the first patients.

These documents were created as “draft” versions: